Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share News

12345678910

Hutchmed drugs stay on NRDL; Tazverik added to new insurance list

8th Dec 2025 11:15

(Alliance News) - Hutchmed China Ltd on Monday said several of its oncology medicines will continue to be reimbursed under China's national insurance scheme next year, while one of its newer cancer drugs has secured a place on the country's first-ever commercial insurance drug list. Read More

LONDON BROKER RATINGS: JPMorgan cuts M&G, UBS cuts Trainline

8th Dec 2025 09:39

(Alliance News) - The following London-listed shares received analyst recommendations on Monday morning and on Friday: Read More

Zero-tariff deal with US to cost NHS GBP1 billion, No 10 says

2nd Dec 2025 14:29

(Alliance News) - A deal that gives the US zero tariffs on its imports of UK pharmaceuticals in return for the National Health Service raising spending on medicines will cost around GBP1 billion, Downing Street has said. Read More

AstraZeneca gets closer to US approval for hypertension drug

2nd Dec 2025 11:50

(Alliance News) - AstraZeneca PLC on Tuesday announced that its new drug application under US Food & Drug Administration priority review for its selective inhibitor baxdrostat for certain patients has been accepted. Read More

AstraZeneca gets closer to US approval for hypertension drug

2nd Dec 2025 11:50

(Alliance News) - AstraZeneca PLC on Tuesday announced that its new drug application under US Food & Drug Administration priority review for its selective inhibitor baxdrostat for certain patients has been accepted. Read More

US to zero out tariffs on UK pharmaceuticals under trade deal

1st Dec 2025 17:50

(Alliance News) - The US on Monday exempted British pharmaceuticals from import tariffs under a unique deal which sees the UK increase spending on American drugs by 25%. Read More

Faron appoints former AstraZeneca Netherlands finance chief as CFO

1st Dec 2025 14:07

(Alliance News) - Faron Pharmaceuticals Ltd on Monday said it has appointed Jurriaan Dekkers as the company’s chief financial officer. Read More

AstraZeneca jab could help people with severe asthma come off steroids

27th Nov 2025 06:45

(Alliance News) - A monthly injection could help people with severe asthma come off daily steroid tablets entirely without any impact on symptoms, a trial has found. Read More

Polar Capital Global Healthcare has "overwhelming" shareholder support

26th Nov 2025 09:02

(Alliance News) - Polar Capital Global Healthcare Trust PLC on Wednesday hailed "a very strong statement" in the result of its tender offer for shares, with nearly 80% of its shareholders choosing to stay invested. Read More

Medicare announces discounts on 15 drugs, including Ozempic and Wegovy

26th Nov 2025 05:56

(Alliance News) - The US government on Tuesday announced cuts to the prices of 15 drugs through the Medicare health insurance system, including major discounts on the price of diabetes and weight loss drugs Wegovy and Ozempic. Read More

AstraZeneca's Imfinzi wins US approval for gastroesophageal cancer

25th Nov 2025 20:18

(Alliance News) - AstraZeneca PLC on Tuesday said Imfinzi has been approved in the US as the first and only perioperative immunotherapy for patients with early gastric and gastroesophageal cancers. Read More

AstraZeneca unveils USD2 billion manufacturing investment in Maryland

21st Nov 2025 21:59

(Alliance News) - AstraZeneca PLC on Friday announced plans to invest USD2 billion to expand its long-standing manufacturing footprint in Maryland. Read More

AstraZeneca gets US approval for Koselugo for rare genetic disorder

20th Nov 2025 09:06

(Alliance News) - AstraZeneca PLC on Thursday said US regulators have approved its drug Koselugo for use in adults with neurofibromatosis type 1, expanding access to a treatment already used in children with the rare genetic condition. Read More

LONDON MARKET OPEN: Stocks sold off on lingering tech worry

18th Nov 2025 08:45

(Alliance News) - Stock prices in Europe opened in the red on Tuesday, following sharp falls in Asia and as equities in New York struggled overnight, with the S&P 500 ending below a key level for the first time a number of months. Read More

LONDON MARKET CLOSE: Stocks hit, bond yields jump amid tax U-turn talk

14th Nov 2025 17:03

(Alliance News) - Stocks fell and bonds yields spiked in volatile trading on Friday amid uncertainty over UK budget proposals after an apparent u-turn on tax policy by Chancellor Rachel Reeves. Read More

DIRECTOR DEALINGS: Springfield Properties chair banks GBP2.6 million

14th Nov 2025 11:21

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced this week and not separately reported by Alliance News: Read More

LONDON BROKER RATINGS: RBC and Deutsche like SSE; Barclays likes Wizz

14th Nov 2025 10:00

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More

LONDON BROKER RATINGS: Jefferies cuts Croda; Deutsche cuts Ashmore

11th Nov 2025 09:50

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More

AstraZeneca says Baxdrostat reduces 24-hour systolic blood pressure

10th Nov 2025 04:32

(Alliance News) - AstraZeneca PLC on Sunday announced results from the phase 3 trial of its Baxdrostat treatment which showed a statistically significant reduction in the systolic blood pressure of patients with resistant hypertension. Read More

LONDON BROKER RATINGS: Goldman Sachs cuts Weir; UBS ups British Land

7th Nov 2025 10:14

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More

12345678910
FTSE 100 Latest
Value9,655.53
Change13.52